Candidate 2 of 2 for Director:

Geetha Sivasubramanian, MD, FIDSA
For those of us working in endemic regions, coccidioidomycosis is part of everyday clinical care. Yet much of this work happens in parallel, with limited opportunities to share experiences across regions facing the same challenges. This is where the Coccidioidomycosis Study Group (CSG) matters, connecting clinical, research, and public health perspectives that rarely meet in one place. It is one of the few forums where these realities are openly discussed and learned from across disciplines. I have
seen firsthand how this space supports those of us working in endemic regions. By serving on the Board, I hope to help sustain and strengthen this exchange.
Caring for patients with severe and chronic manifestations of disease has reshaped how I think about progress in coccidioidomycosis. Many of the hardest challenges are not diagnostic or therapeutic alone. Patients face language barriers, medication toxicity, transportation limitations, and fragmented systems that make long-term follow-up difficult. I have seen how easily patients are lost to care and how much
their outcomes depend on factors beyond antifungal selection. These experiences have led me to value work that connects scientific advances with implementation, continuity of care, and access.
I would bring to the Board the perspective of a clinician practicing in a high-burden, resource-limited region, where social determinants of health and care infrastructure directly shape outcomes. My experience spans safety-net systems, community clinics, and sustained partnerships with public health agencies and community organizations to improve awareness, testing, and linkage to care. This work requires coordinating across clinical, laboratory, public health, and community stakeholders, and has
shaped my collaborative approach to leadership and problem-solving.
If selected, I would actively participate in Board discussions and committee work, focusing on making our work more usable for frontline clinicians and public health partners. I am especially interested in efforts that support practical guidance and implementation-focused research around long-term management, adherence, medication toxicity, and care coordination.
I also view Board service as an opportunity to support the next generation of clinicians and investigators in this field. In my work with medical students, residents, fellows, and pipeline programs in the Central Valley, I see how often trainees encounter coccidioidomycosis in a single rotation without clear pathways for sustained engagement. Without mentorship and connection to a broader community, that early interest can fade. Through mentorship, collaboration, and structured opportunities, the CSG can help more physicians develop the skills and confidence to care for patients with coccidioidomycosis and remain engaged in this work over time.
As endemic areas for coccidioidomycosis continue to expand and more clinicians encounter this complex disease, the role of the CSG as a unifying platform for shared learning and guidance becomes even more vital. I would welcome the opportunity to contribute to this work and help strengthen the community committed to improving care and outcomes for patients with coccidioidomycosis.
CV: Geetha Sivasubramanian